Dr Fiona Godlee, Editor-in-Chief of the BMJ, recently published a piece arguing that ‘data transparency is the only way‘. This News Blog has featured a number of posts where many large RCTs have left a matter in contention – deworming children, clot busters for stroke, and vitamin A prophylaxis in children. When this happens, a dispute typically opens up about nuances in the handling of the data that might have introduced bias; bias so small that it is only material when the trials are large and hence the confidence limits narrow. The right policy is to stick the anonymised data in the public domain so that everyone can have a go at it. What is not okay, is to assume that one lot have the moral high ground – not industry, nor academics, nor editors, nor even CLAHRC Directors!
— Richard Lilford, CLAHRC WM Director
- Godlee F. Data transparency is the only way. BMJ. 2016; 352: i1261.